China Vitamin Industry Report,2014-2017
  • June 2014
  • Hard Copy
  • USD $2,550
  • Pages:117
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: QJC008
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,750
      

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin E takes up about 30%. Since 2009, influenced by the sluggish external demand and declining prices, China's output of vitamin products has been declining sharply. In 2013, the output of various types of vitamin products in China was about 201,000 tons, down 7.4% YoY.

China is also the world's largest export base of vitamins, mainly vitamin C, vitamin E and pantothenic calcium. In 2013, China's export volume of vitamin C and vitamin E accounted for 55.0% and 23.7% of total export volume over the same period. In addition, the proportions of D or DL-pantothenic acid (i.e. vitamin B3 or B5) have increased to 5.7%.

Chinese vitamin producers fall into two types: large integrated pharmaceutical enterprises and professional vitamin producers. In 2009-2013, large integrated pharmaceutical enterprises such as North China Pharmaceutical Co.,Ltd and Northeast Pharmaceutical Group Co.,Ltd mostly had heavy burden historically and encountered operating difficulties and development obstacles, thus their ratio of R & D investment in total revenue was less than 3%; while professional vitamin producers like NHU, Kingdomway, and Brother Enterprises Holding kept higher gross margins of their products, with R & D investment generally accounting for more than 4% of revenue.

In recent years, the global and Chinese vitamin market has been exhibiting a monopolistic competition pattern. CSPC Pharmaceutical Group, North China Pharmaceutical, Northeast Pharmaceutical, Aland (Jiangsu) Nutraceutical, Shandong Luwei Pharmaceutical and other Chinese companies with production capacity of more than 15,000 tons, are the major suppliers in the global VC market. Zhejiang Medicine, NHU, and PKU Healthcare together shared about 50% of the global total capacity of VE. NHU, Zhejiang Medicine and Kingdomway three companies together accounted for 40%-50% of the global total capacity of VA.

Since the vitamin industry has high technical barriers, the existing major producers have already formed their own competitive advantages and the cost of quitting is high. So it is estimated that in 2014-2017, the monopolistic competition pattern in China vitamin industry will persist.

维生素 英文_副本.jpg

"China Vitamin Industry Report, 2014-2017" provided by ResearchInChina covers the following:
20120114.gifChina vitamin market supply and demand, import and export, competition pattern and development projections;
20120114.gifDevelopment status, competition pattern, import and export, market prices of VC, VA, VB, VE products in China;
20120114.gifOperation, vitamin business and development prospects of 16 global and Chinese vitamin companies.

1 Overview of Vitamins 
1.1 Definition
1.2 Classification
1.3 Global Overview

2 Development of China Vitamin Industry 
2.1 Status Quo
2.2 Import and Export
2.2.1 Export
2.2.2 Import
2.3 Competition Pattern

3 China Vitamin Market Segments
3.1 VA
3.1.1 Development Status
3.1.2 Import and Export
3.1.3 Market Price
3.2 VB
3.2.1 D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5)
3.2.2 VB6
3.2.3 VB1
3.2.4 VB2
3.2.5 Choline Chloride (VB4)
3.2.6 VB12
3.3 VC
3.3.1 Development Status
3.3.2 Import and Export
3.3.3 Market Price
3.4 VE
3.4.1 Development Status
3.4.2 Import and Export
3.4.3 Market Price
3.5 Others

4 Key Enterprises
4.1 DSM
4.1.1 Profile
4.1.2 Operation
4.1.3 Vitamin Business
4.1.4 R&D
4.1.5 Business in China
4.2 BASF
4.2.1 Profile
4.2.2 Operation
4.2.3 Vitamin Business
4.2.4 Business in China
4.3 Adisseo
4.3.1 Profile
4.3.2 Vitamin Business
4.3.2 R & D
4.4 CSPC Pharmaceutical Group Limited
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Vitamin Business
4.4.5 R & D
4.5 Shandong Xinhua Pharmaceutical 
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Vitamin Business
4.5.5 R & D
4.5.6 Major Clients
4.6 North China Pharmaceutical
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.5.4 Vitamin Business
4.6.5 R & D
4.6.6 Major Clients
4.7 PKU Healthcare 
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Vitamin Business
4.7.5 R & D
4.7.6 Major Clients
4.8 Zhejiang Medicine Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Vitamin Business
4.8.5 R & D
4.8.6 Major Clients
4.9 Northeast Pharmaceutical
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Vitamin Business
4.9.5 R & D
4.9.6 Major Clients
4.10 Hubei Guangji Pharmaceutical
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Vitamin Business
4.10.5 R & D
4.10.6 Major Clients
4.11 NHU
4.11.1Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Vitamin Business
4.11.5 R & D
4.11.6 Major Clients
4.12 Brother Enterprises Holding
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Vitamin Business
4.12.5 R & D
4.12.6 Major Clients
4.13 Zhejiang Hangzhou Xinfu Pharmaceutical 
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Vitamin Business
4.13.5 R & D
4.13.6Major Clients
4.14 Kingdomway
4.14.1 Profile
4.14.2 Operation
4.14.3 Revenue Structure
4.14.4 R & D
4.14.5 Major Clients
4.15 Henan Topfond Pharmaceutical Co.,Ltd
4.15.1 Profile
4.15.2 Operation
4.15.3 Vitamin Business
4.15.4 R & D
4.16 Xinfa Pharmaceutical
4.16.1 Profile
4.16.2 Operation

5 Forecast and Outlook
5.1 Output and Product Mix
5.2 Competition Pattern
Classification and Effect of Vitamins
Global Sales of Vitamin and Mineral Medicine, 2006-2013
Global Consumption Structure of Vitamins (by Application) 
Global Consumption Structure of Major Vitamin Products (by Application) 
Output of Vitamin Products in China, 2009-2013
Output Structure of Vitamin Products in China, 2012
China's Export Volume, Export Value and Average Export Price of Vitamins, 2009-2014
Structure of China's Vitamin Export Volume, by Product, 2008-2013
Export Destinations of China's Vitamins, 2013
China's Import Volume, Import Value and Import Average Price of Vitamins, 2010-2014
Structure of China's Vitamin Import Volume, by Product, 2008-2013
Import Sources of Vitamins in China, 2013
Major Vitamin A Enterprises and Their Output in China, 2011-2012
China's Export Volume of VA and YoY Growth, 2009-2014
China's Export Value of VA and YoY Growth, 2009-2014
Export Destinations of China's VA, 2013
China's Import Volume of VA and YoY Growth, 2009-2014
China's Import Value of VA and YoY Growth, 2009-2014
Import Sources of VA in China, 2013
Market Prices of VA in China, 2009-2014
China's Export Volume, Export Value and Export Average Price of D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5), 2009-2014
China's Import Volume, Import Value and Import Average Price of D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5), 2009-2014
Market Prices of Calcium Pantothenate (VB5) in China, 2009-2014
Market Prices of Niacin (VB3) in China 2009-2014
China's Export Volume, Export Value and Export Price of VB6, 2009-2014
Market Price of VB6 in China, 2009-2014
Output and Export Volume of Major Vitamin B1 Producers in China, 2011-2012
China's Export Volume, Export Value and Export Price of VB1, 2009-2014
Market Price of VB1 in China, 2009-2014
Chinese Major Producers' Output and Export Volume of Vitamin B2 and Its Salts, 2012
China's Export Volume, Export Value and Export Price of VB2, 2009-2014
Market Prices of VB2 (80%) in China, 2009-2014
Structure (%) of China's Choline Chloride Exporting Countries, by Export Volume, 2010-2012
Market Prices of Choline Chloride (VB4) in China, 2009-2014
China's Export Volume, Export Value and Export Price of VB12, 2009-2014
Market Price of VB12 (Liquid Phase 1%) in China, 2009-2013
Major Vitamin C Enterprises and Their Output in China, 2012
China's Export Volume, Export Value and Export Price of VC, 2009-2014
Export Destinations of China's VC , 2013
China's Import Volume, Import Value and Import Price of VC, 2009-2014
Import Sources of VC in China, 2013
Market Price Trends of Coated VC in China, 2009-2014
Major VE Enterprises and Their Output in China, 2012
China's VE Export Volume and YoY Growth, 2009-2014
China's Export Value and Average Price of VE, 2009-2014
Export Destinations of China's VE, 2013
China's VE Import Volume and YoY Growth, 2009-2014
China’s Import Value and Import Average Price of VE, 2009-2014
Import Sources of VE in China, 2013
Market Price Trends of VE in China, 2009-2014
China's Output, Export Volume and Growth of Minority Vitamins, 2011-2012
Sales and Net Income of DSM, 2009-2014
Major Businesses of DSM
Sales Structure of DSM, by Business, 2009-2013
Sales and EBITDA of DSM's Nutritional Business, 2009-2014
R & D Costs and % of Revenue of DSM, 2009-2013
DSM's Sales in China, 2009-2013
Sales and Net Income of BASF, 2009-2013
Sales, EBITDA and % in Revenue of BASF's Performance Products, 2009-2013 
Sales of Adisseo, 2008-2012
Revenue and Net Income of CSPC, 2009-2013
Operating Revenue and Profit of CSPC, by Product, 2010-2012
Revenue Breakdown of CSPC, by Region, 2010-2013
Revenue Structure of CSPC, by Region, 2012-2013
CSPC's Output and Export Volume of Vitamins, by Product, 2012 
CSPC's Revenue of VC Business, 2010-2013
Revenue and Net Income of Xinhua Pharmaceutical, 2008-2014
Operating Revenue Structure of Xinhua Pharmaceutical, by Product, 2008-2013
Revenue of Xinhua Pharmaceutical, by Product, 2008-2013
Xinhua Pharmaceutical's Gross Margin of Preparation Products, 2008-2013
R & D Costs and % in Revenue of Xinhua Pharmaceutical, 2010-2013
Xinhua Pharmaceutical's Revenue from Top 5 Clients and % in Total Revenue, 2008-2013
Revenue and Net Income of North China Pharmaceutical, 2008-2014
Operating Revenue Structure of North China Pharmaceutical, by Region, 2008-2013
Revenue of North China Pharmaceutical, by Region, 2008-2013
Operating Revenue Structure of North China Pharmaceutical, by Product, 2009-2013
Revenue of North China Pharmaceutical, by Product, 2009-2013
North China Pharmaceutical's Subsidiaries Engaging in Vitamin Business
North China Pharmaceutical's Output and Export Volume of Some APIs, 2012 
North China Pharmaceutical's Gross Margin of Vitamin Products, 2008-2013
R & D Costs and % in Revenue of North China Pharmaceutical, 2008-2013 
North China Pharmaceutical's Revenue from Top5 Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of PKU Healthcare, 2008-2014
Operating Revenue Structure of PKU Healthcare, by Region, 2008-2013
Revenue of PKU Healthcare, by Region, 2008-2013
Operating Revenue Structure of PKU Healthcare, by Sector, 2008-2013
Revenue of PKU Healthcare, by Sector, 2008-2013
Major Vitamin Products of PKU Healthcare 
R & D Costs and % in Revenue of PKU Healthcare, 2011-2013 
North China Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Zhejiang Medicine, 2009-2014
Operating Revenue Structure of Zhejiang Medicine, by Region, 2009-2013 
Revenue of Zhejiang Medicine, by Region, 2009-2013
Operating Revenue Structure of Zhejiang Medicine, by Sector, 2009-2013 
Revenue of Zhejiang Medicine, by Sector, 2009-2013
Zhejiang Medicine's Output and Export Volume of Some APIs, 2012 
R & D Costs and % in Revenue of Zhejiang Medicine, 2009-2013 
Zhejiang Medicine's Revenue from Top5 Clients and % of Total Revenue, 2009-2013
Revenue and Net Income of Northeast Pharmaceutical, 2009-2014
Operating Revenue Structure of Northeast Pharmaceutical, by Region, 2009-2013 
Revenue of Northeast Pharmaceutical, by Region, 2009-2013 
Operating Revenue Structure of Northeast Pharmaceutical, by Sector, 2009-2013 
Revenue of Northeast Pharmaceutical, by Sector, 2009-2013 
Northeast Pharmaceutical's Output and Export Volume of VC Products, 2011-2012
Expenditure for Development Project of Northeast Pharmaceutical, 2010-2013
Northeast Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
Revenue and Net Income of Guangji Pharmaceutical, 2008-2014
Operating Revenue Structure of Guangji Pharmaceutical, by Region, 2008-2013 
Revenue of Guangji Pharmaceutical, by Region, 2008-2013 
Operating Revenue Structure of Guangji Pharmaceutical, by Sector, 2008-2013 
Revenue of Guangji Pharmaceutical, by Sector, 2008-2013 
Guangji Pharmaceutical's Subsidiaries Engaging in Vitamin Business, 2013
Net Income of Guangji Pharmaceutical's Subsidiaries Engaging in Vitamin Business, 2010-2013
Guangji Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of NHU, 2008-2014
Operating Revenue Structure of NHU, by Region, 2008-2013 
Revenue of NHU, by Region, 2008-2013 
Operating Revenue Structure of NHU, by Sector, 2008-2013 
Revenue of NHU, by Sector, 2008-2011 
Operating Revenue Structure of NHU, by Sector, 2012-2013 
Revenue of NHU, by Sector, 2012-2013 
NHU's Subsidiaries Engaging in Vitamin Business
Net Income of NHU's Subsidiaries Engaging in Vitamin Business, 2009-2013
NHU's Gross Margin of Vitamin Products, 2008-2011
NHU's Gross Margin of Vitamin Products, 2011-2013
R & D Costs and % in Revenue of NHU, 2009-2013 
NHU's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Brother, 2008-2014
Operating Revenue Structure of Brother, by Region, 2008-2013 
Revenue of Brother, by Region, 2008-2013 
Operating Revenue Structure of Brother, by Product, 2008-2013 
Revenue of Brother, by Product, 2008-2013 
Brother's Gross Margin of Vitamin Products, 2008-2013
R & D Costs and % in Revenue of Brother, 2008-2013 
Brother's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Xinfu Pharmaceutical, 2009-2014
Operating Revenue Structure of Xinfu Pharmaceutical, by Region, 2009-2013 
Revenue of Xinfu Pharmaceutical, by Region, 2009-2013 
Operating Revenue Structure of Xinfu Pharmaceutical, by Product, 2009-2013 
Revenue of Xinfu Pharmaceutical, by Product, 2009-2013 
Xinfu Pharmaceutical's Gross Margin of Vitamin Products, 2009-2013
R & D Costs and % in Revenue of Xinfu Pharmaceutical, 2009-2013 
Xinfu Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
Revenue and Net Income of Kingdomway, 2009-2014
Operating Revenue Structure of Kingdomway, by Region, 2009-2013 
Revenue of Kingdomway, by Region, 2009-2013 
Operating Revenue Structure of Kingdomway, by Product, 2009-2013 
Revenue of Kingdomway, by Product, 2009-2013 
Kingdomway's Gross Margin of Vitamin Related Products, 2009-2013
R & D Costs and % in Revenue of Kingdomway, 2009-2013 
Kingdomway's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
Revenue and Net Income of Topfond Pharmaceutical, 2008-2011
Xinfa Pharmaceutical's Vitamin Products, Applications and Technical Standards
China's Output of Vitamin Products, 2013-2017E

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

China Pharmaceutical Chain Industry Report, 2010

Recent years have seen rapid growth of China’s pharmaceutical retail market, with expanding scale of chain enterprises and increasing number of drugstores, thanks to a fast-growing pharmaceutical indu...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统